These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37665290)

  • 1.
    Kim DH; Zo S; Kim SY; Jhun BW
    Ann Lab Med; 2024 Jan; 44(1):92-96. PubMed ID: 37665290
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Brown-Elliott BA; Rubio A; Wallace RJ
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria.
    Pennings LJ; Ruth MM; Wertheim HFL; van Ingen J
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G; Wu L; Zheng Q; Jiang X
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Aragaw WW; Cotroneo N; Stokes S; Pucci M; Critchley I; Gengenbacher M; Dick T
    Microbiol Spectr; 2022 Feb; 10(1):e0132121. PubMed ID: 35019671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sun Q; Liao X; Wang C; Jiang G; Yang J; Zhao J; Huang H; Wang G; Li H
    J Med Microbiol; 2022 Jun; 71(6):. PubMed ID: 35708979
    [No Abstract]   [Full Text] [Related]  

  • 8. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease.
    Kim DH; Kim BG; Kim SY; Huh HJ; Lee NY; Koh WJ; Kim H; Kwon OJ; Jhun BW
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin.
    Ferro BE; Meletiadis J; Wattenberg M; de Jong A; van Soolingen D; Mouton JW; van Ingen J
    Antimicrob Agents Chemother; 2016 Feb; 60(2):1097-105. PubMed ID: 26643335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease.
    Fujiwara K; Uesugi F; Furuuchi K; Tanaka Y; Yoshiyama T; Saotome M; Ohta K; Mitarai S; Morimoto K
    Microbiol Spectr; 2021 Dec; 9(3):e0192821. PubMed ID: 34878300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
    Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
    J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
    Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
    Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Nontuberculous Mycobacteria in Tuberculosis suspects, Southwest of China, 2017-2022.
    Wang DM; Liu H; Zheng YL; Xu YH; Liao Y
    Front Cell Infect Microbiol; 2023; 13():1282902. PubMed ID: 38029240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kim DH; Kim SY; Koh WJ; Jhun BW
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0230620. PubMed ID: 33903101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y; Adler A
    Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trend of nontuberculous mycobacteria species and minimal inhibitory concentration in a referral laboratory in Korea from 2013 to 2019.
    Kim YJ; Kim S; Ham H; Yu S; Choo HJ; Kim HJ; Heo R; Choi G; Kim SH; Lee HJ
    J Infect Public Health; 2024 Feb; 17(2):212-216. PubMed ID: 38113818
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Zhu R; Shang Y; Chen S; Xiao H; Ren R; Wang F; Xue Y; Li L; Li Y; Chu N; Huang H
    Microbiol Spectr; 2022 Dec; 10(6):e0137222. PubMed ID: 36250885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.